Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marcel C.J. Jonker"'
Autor:
Tomas Janssen, Marcel C.J. Jonker, Corrie A.M. Marijnen, Rob Kessels, Charlotte L. Zuur, Arash Navran, Jan-Jakob Sonke, Jan de Boer, Olga Hamming-Vrieze, Abrahim Al-Mamgani
Publikováno v:
Radiotherapy and Oncology, 162, 170-177. ELSEVIER IRELAND LTD
Background and purpose: We aim to retrospectively investigate whether reducing GTV to high-risk CTV margin will significantly reduce acute and late toxicity without jeopardizing outcome in head-and neck squamous cell carcinoma (HNSCC) treated with de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d43acf4f9e124bd9b79e656f9b5e491a
https://doi.org/10.1016/j.radonc.2021.07.016
https://doi.org/10.1016/j.radonc.2021.07.016
Autor:
Suzanne van Beek, Jeroen B. van de Kamer, Olga Hamming-Vrieze, Peter Remeijer, Abrahim Al-Mamgani, Arash Navran, Marcel C.J. Jonker
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology
Technical Innovations & Patient Support in Radiation Oncology, Vol 12, Iss, Pp 34-40 (2019)
Technical Innovations & Patient Support in Radiation Oncology, Vol 12, Iss, Pp 34-40 (2019)
Highlights • Protocolised evaluation of daily CBCT by RTTs result in re-planning in 10%. • Patients treated with chemoradiotherapy have the highest probability of requiring re-planning. • Most anatomical changes visible on CBCT were detected in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26b896d17cd19322d924b7e432922a27
https://doi.org/10.1016/j.tipsro.2019.11.001
https://doi.org/10.1016/j.tipsro.2019.11.001
Autor:
Arash Navran, Wilma D. Heemsbergen, Olga Hamming-Vrieze, Marcel Verheij, Tomas Janssen, Charlotte L. Zuur, Abrahim Al-Mamgani, Marcel C.J. Jonker, Michiel W. M. van den Brekel, Peter Remeijer, Jan-Jakob Sonke
Publikováno v:
Radiotherapy and Oncology, 130, 1, pp. 25-31
Radiotherapy and Oncology, 130, 25-31. Elsevier Ireland Ltd
Radiotherapy and Oncology, 130, 25-31
Radiotherapy and Oncology, 130, 25-31. Elsevier Ireland Ltd
Radiotherapy and Oncology, 130, 25-31
Contains fulltext : 203208.pdf (Publisher’s version ) (Closed access) BACKGROUND AND PURPOSE: In recent decades, outcomes of patients with head and neck cancer (HNC) have improved as a result of implementing several strategies, such as chemoradiati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9988d3eb6349d90eaf7793bf426ead
https://doi.org/10.1016/j.radonc.2018.06.032
https://doi.org/10.1016/j.radonc.2018.06.032
Autor:
Pieter D. de Veij Mestdagh, Marcel C.J. Jonker, Maarten L. Donswijk, Willem H. Schreuder, W. Martin C. Klop, Wouter V. Vogel, Abrahim Al-Mamgani
Publikováno v:
European Archives of Oto-Rhino-Laryngology, 275(8), 2135-2144. SPRINGER
To investigate the feasibility of lymph drainage mapping (LDM) using SPECT/CT to help select head and neck cancer (HNSCC) patients for unilateral elective neck irradiation (ENI). Patients with lateralized HNSCC treated with radiotherapy routinely und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d04851a2ad9244d8c3de7e81893577
https://hdl.handle.net/1887/3280424
https://hdl.handle.net/1887/3280424
Autor:
B. Zupan-Kajcovski, J. H. Schagen van Leeuwen, A. P. Brandenburg, W.J. van Driel, R. A. Tupker, Marjanka K. Schmidt, M.W.M. van den Brekel, R. de Bree, Eric Vermeulen, F.E. van Leeuwen, Victor J. Verwaal, T. J. Stoof, L. Plusjé, E. Vermeulen, Marcel C.J. Jonker, Richard M. Brohet, Neil K. Aaronson, Susanne Rebers, Caroline J. Bax, R. A. de Leeuw, Jan C. Grutters, W. J. W. Bos
Publikováno v:
PLoS ONE
PLoS ONE [E], 11(3). Public Library of Science
Rebers, S, Vermeulen, E, Brandenburg, A P, Stoof, T J, Zupan-Kajcovski, B, Bos, W J W, Jonker, M, Bax, C J, van Driel, W J, Verwaal, V J, van den Brekel, M W M, Grutters, J C, Tupker, R A, Plusje, L, de Bree, R, van Leeuwen, J H S, Vermeulen, E G J, de Leeuw, R A, Brohet, R, Aaronson, N K, Van Leeuwen, F E & Schmidt, M K 2016, ' A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice ', PLoS ONE, vol. 11, no. 3, e0152509 . https://doi.org/10.1371/journal.pone.0152509
PLoS ONE, 11(3):e0152509. Public Library of Science
PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)
PLoS ONE [E], 11(3). Public Library of Science
Rebers, S, Vermeulen, E, Brandenburg, A P, Stoof, T J, Zupan-Kajcovski, B, Bos, W J W, Jonker, M, Bax, C J, van Driel, W J, Verwaal, V J, van den Brekel, M W M, Grutters, J C, Tupker, R A, Plusje, L, de Bree, R, van Leeuwen, J H S, Vermeulen, E G J, de Leeuw, R A, Brohet, R, Aaronson, N K, Van Leeuwen, F E & Schmidt, M K 2016, ' A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice ', PLoS ONE, vol. 11, no. 3, e0152509 . https://doi.org/10.1371/journal.pone.0152509
PLoS ONE, 11(3):e0152509. Public Library of Science
PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)
BackgroundDespite much debate, there is little evidence on consequences of consent procedures for residual tissue use. Here, we investigated these consequences for the availability of residual tissue for medical research, clinical practice, and patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb524d66d9c5365604f99c800a7d5a85
http://www.scopus.com/inward/record.url?scp=84962713412&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=84962713412&partnerID=8YFLogxK